Frank H. Andersen

Frank H. Andersen joined Jyske Bank Equity Research in 2004 as a healthcare analyst. Frank is responsible for covering Danish biotech and medtech companies. Companies under coverage include Genmab, Bavarian Nordic, Coloplast, William Demant and GN. Also I have partial responsibility for coverage of Novo Nordisk, H. Lundbeck, Neurosearch and ALK-Abelló.

I performed the role of Consultant working closely with the President of the company on an analysis to evaluate the company’s options to enter the Spanish and Italian market. Also I was responsible for researching new standards for Poolbarrier’s existing market in France. My analysis helped the company to launch their products in new markets and thereby raising the overall earning for the company.

I performed the role of Corporate Finance Analyst working directly with the CFO of the company. My tasks included company valuation, market research, investment calculations, upper-management consulting, preparing presentations packages and management reporting.